Abstract

Background: Geographic variation in healthcare quality, including an urban-rural difference, is well recognized. For stroke care, we were interested in the relationship with stroke center certification and access to neurological services. Hypothesis: We assessed the hypothesis that the use of thrombolytic therapy (t-PA) is associated with stroke certification level and access to neurological services. Methods: Performance measure data in the 2015 Hospital Compare, a CMS quality reporting system, were used to document the gap in care quality among hospitals according to large, medium, small-metro, and non-metro areas and Joint Commission (JC) certification. Regression analysis was used to estimate the association between t-PA use and certification level or access to neurological services. Results: On average, non-metro hospitals performed worse than metro hospitals on JC-endorsed stroke quality measures; the biggest disparity was in the use of t-PA for eligible patients arriving within 2 hours (STK-4). Certified stroke centers in every geographic designation provided higher quality of care; however, a large variation was observed among non-certified hospitals (Figure). Regression analysis suggested that improvements in certification or access were associated with 45% and 21% absolute improvements, respectively, in the percent of patients receiving t-PA (Table). Conclusion: The large quality gap in stroke care between metro and non-metro areas can, in part, be addressed by approaches to achieve stroke center certification or to adopt decision support systems such as telemedicine.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call